News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
784,883 Results
Type
Article (53815)
Company Profile (643)
Press Release (730423)
Multimedia
Podcasts (124)
Webinars (19)
Section
Business (225640)
Career Advice (2986)
Deals (38780)
Drug Delivery (122)
Drug Development (87567)
Employer Resources (189)
FDA (17620)
Job Trends (16719)
News (381147)
Policy (36741)
Tag
Academia (2791)
Academic (2)
Accelerated approval (11)
Adcomms (28)
Allergies (106)
Alliances (55306)
ALS (119)
Alzheimer's disease (1544)
Antibody-drug conjugate (ADC) (180)
Approvals (17587)
Artificial intelligence (361)
Autoimmune disease (36)
Automation (19)
Bankruptcy (401)
Best Places to Work (12431)
BIOSECURE Act (22)
Biosimilars (133)
Biotechnology (440)
Bladder cancer (99)
Brain cancer (39)
Breast cancer (384)
Cancer (3054)
Cardiovascular disease (242)
Career advice (2518)
Career pathing (34)
CAR-T (203)
CDC (38)
Cell therapy (559)
Cervical cancer (24)
Clinical research (71742)
Collaboration (1103)
Company closure (3)
Compensation (710)
Complete response letters (33)
COVID-19 (2860)
CRISPR (66)
C-suite (355)
Cystic fibrosis (119)
Data (3081)
Decentralized trials (2)
Denatured (40)
Depression (74)
Diabetes (370)
Diagnostics (6902)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (160)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (133)
Earnings (94942)
Editorial (47)
Employer branding (24)
Employer resources (162)
Events (127523)
Executive appointments (906)
FDA (19340)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1005)
Gene editing (146)
Generative AI (34)
Gene therapy (428)
GLP-1 (915)
Government (4958)
Grass and pollen (6)
Guidances (181)
Healthcare (20352)
HIV (43)
Huntington's disease (31)
IgA nephropathy (44)
Immunology and inflammation (181)
Immuno-oncology (10)
Indications (40)
Infectious disease (3048)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (66)
Intellectual property (125)
Interviews (556)
IPO (17747)
IRA (52)
Job creations (4749)
Job search strategy (2088)
Kidney cancer (14)
Labor market (55)
Layoffs (582)
Leadership (27)
Legal (9294)
Liver cancer (83)
Longevity (12)
Lung cancer (426)
Lymphoma (215)
Machine learning (11)
Management (64)
Manufacturing (435)
MASH (98)
Medical device (14552)
Medtech (14557)
Mergers & acquisitions (21762)
Metabolic disorders (944)
Multiple sclerosis (103)
NASH (21)
Neurodegenerative disease (136)
Neuropsychiatric disorders (38)
Neuroscience (2285)
NextGen: Class of 2025 (7359)
Non-profit (4830)
Now hiring (48)
Obesity (483)
Opinion (287)
Ovarian cancer (104)
Pain (117)
Pancreatic cancer (125)
Parkinson's disease (196)
Partnered (23)
Patents (318)
Patient recruitment (173)
Peanut (55)
People (63753)
Pharmaceutical (132)
Pharmacy benefit managers (25)
Phase I (22301)
Phase II (31462)
Phase III (23600)
Pipeline (1697)
Policy (237)
Postmarket research (2893)
Preclinical (9628)
Press Release (71)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (277)
Rare diseases (516)
Real estate (6881)
Recruiting (73)
Regulatory (25186)
Reports (55)
Research institute (2515)
Resumes & cover letters (469)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (97)
Series A (172)
Series B (118)
Service/supplier (28)
Sickle cell disease (67)
Special edition (21)
Spinal muscular atrophy (160)
Sponsored (35)
Startups (4156)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (82)
Vaccines (893)
Venture capital (58)
Weight loss (318)
Women's health (50)
Worklife (20)
Date
Today (101)
Last 7 days (389)
Last 30 days (1990)
Last 365 days (33163)
2025 (17939)
2024 (37648)
2023 (42374)
2022 (53730)
2021 (58437)
2020 (57104)
2019 (50285)
2018 (38166)
2017 (35686)
2016 (35935)
2015 (41954)
2014 (36350)
2013 (31667)
2012 (33484)
2011 (33748)
2010 (32130)
Location
Africa (962)
Alabama (70)
Alaska (7)
Arizona (264)
Arkansas (14)
Asia (45732)
Australia (7606)
California (7768)
Canada (2414)
China (723)
Colorado (339)
Connecticut (346)
Delaware (203)
Europe (101975)
Florida (1150)
Georgia (257)
Hawaii (2)
Idaho (63)
Illinois (702)
India (32)
Indiana (382)
Iowa (18)
Japan (239)
Kansas (114)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1089)
Massachusetts (5944)
Michigan (271)
Minnesota (481)
Mississippi (3)
Missouri (99)
Montana (31)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2184)
New Mexico (31)
New York (2176)
North Carolina (1233)
North Dakota (10)
Northern California (3357)
Ohio (252)
Oklahoma (17)
Oregon (46)
Pennsylvania (1660)
Puerto Rico (18)
Rhode Island (39)
South America (1383)
South Carolina (36)
South Dakota (1)
Southern California (2876)
Tennessee (127)
Texas (1180)
United States (29212)
Utah (231)
Virginia (210)
Washington D.C. (80)
Washington State (680)
West Virginia (4)
Wisconsin (83)
784,883 Results for "bain and company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences market, recently revitalized by more industry-friendly policy changes from the government.
February 10, 2025
·
1 min read
·
Tristan Manalac
Funding
Bain Raises $3B for Fourth Fund to Back Promising Life Sciences Companies
Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.
September 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
April 16, 2025
·
2 min read
Press Releases
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
January 28, 2025
·
2 min read
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
Pharm Country
Bain & Company and KLAS study finds 80% of US healthcare providers are accelerating spending on IT and software with AI top of mind
A new study from Bain & Company and KLAS Research shows US healthcare providers are accelerating spending on IT and software.
September 12, 2023
·
5 min read
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
July 16, 2025
·
3 min read
Press Releases
Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
June 20, 2025
·
4 min read
1 of 78,489
Next
